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Objective: To recommend prerequisites for the histo-
pathological evaluation of reduction mammoplasty (RM)
specimens based on an audit in a tertiary care hospital.
Methods: All reduction mammoplasty specimens
received at department of pathology, in a tertiary care
hospital over a 3 years period were re-evaluated retro-
spectively. Medical records were checked for age, family
history of breast cancer, indication for surgery and
radiological evaluation. Pathology reports were reviewed
for number of blocks sampled and diagnosis. A pre-
requisites protocol was developed based upon deficiencies
and impediments noted.
Results: We received a total of 26 cases of reduction
mammoplasty. Only 2 (7.69%) specimens were from
males. The age of the patients ranged from 26 to 50 years.
Indication for surgery was provided in all (100%) of
cases, with macromastia being most prevalent indication.
Family history of breast carcinoma and radiological ev-
idence was absent or not provided in all cases. The
number of blocks prepared were in range of <4 in 17
(73.91%), 5e8 blocks in 5 (19.23%) and 8e12 blocks in 4
cases (15.38%). The main histopathological finding was
fibrocystic change. (n ¼ 12, 46.15%). Specimen radiog-
raphy was not conducted in any case.
Conclusion: There is a need to stratify RM cases as high,
moderate and low risk of breast cancer based on family
history of breast carcinoma, clinical and radiological
evaluation. The high risk cases should be oriented, withy. This is an open access article under the CC BY-NC-ND license
.1016/j.jtumed.2016.01.008
A. Ahmed et al. 135margins inked and extensive sampling done. Specimen
radiography should be carried out in younger patients in
which mammography is not recommended.
Keywords: Breast cancer; Fibrocystic disease; Histopathology;
Reduction mammoplasty; Specimen radiography
 2016 The Authors.
Production and hosting by Elsevier Ltd on behalf of Taibah
University. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Introduction
Reduction mammoplasty (RM) is a common surgical
procedure used for cosmetic reasons, symptomatic macro-
mastia, or correction of asymmetry. RM produces a variable
amount of tissue that is submitted for histopathological
evaluation, with only a small number of random sections
usually being sampled. Most cases turn out to be benign, but
rarely, occult breast carcinomas have been documented.1,2
In 2002, the Royal College of Pathologists circulated a
document, labelled as “Histopathology of limited or no clinical
value”, to all pathologists in theUK.3 This document included
a list of the specimens for which histological examination was
of doubtful or limited significance, thereby making little or no
contribution topatient care. This document primarily aimed to
redirect the focus of pathologists to specimens that are
clinically and diagnostically more apt and relevant. Breast
reduction mammoplasty was considered to be a specimen
needing little histopathological concentration. As the
percentage of incidental carcinoma is very low, no consensus
currently exists regarding benefits of a detailed and thorough
pathological examination.4 Sections from macroscopically
abnormal areas are justified, but the value of random
histology appears minimal.1
Based on the low incidence of pathologically or clinically
important lesions in RM specimens in the last decade,
surgeons have started to consider not sending RM speci-
mens for pathological examination if radiology reveals
nothing suspicious for patients.5 In addition, cost-
effectiveness for histopathological evaluation of RM could
also be considered to be a limiting factor. In the United
States, in 2007, nearly 220,000 RM were performed, and it
was calculated that the total cost to the health care system
for these pathological examinations was $25 million
annually.6,7
The above mentioned trends are currently being debated
and are changing as a result. Occult carcinomas have been
reported in RM specimens, and this finding justifies a highly
detailed histopathological evaluation for all RM specimens.5
Absolute reliance on radiological diagnosis is also not a
preferred modality; for example, Amichetti et al. revealed
that mammographically and ultrasonographically non-
suspicious breasts might yield clinically important histo-
pathological lesions that can alter patient management.8
Increased incidence of breast cancer in patients of
macromastia suggest that this incidence may be a factor
predisposing patients to breast cancer. Therefore, surgeonsshould undertake a preoperative screening consisting of a
recommended triple breast evaluation; a detailed patient
history, specifically any personal or family history of breast
cancer; a clinical examination; and imaging by either a
mammogram or breast ultrasound.9
In our centre, all breast reduction samples are routinely
sent to the histopathology laboratory where microscopic
examination is conducted, regardless of the macroscopic
picture or radiological findings. To the best of our knowl-
edge, no study to date has been undertaken to validate this
approach. In the current study, we conducted an audit of
reduction mammoplasty specimens received in the last three
years in order to evaluate the current submission and diag-
nostic practice with the aim of developing a proper pre-
requisites protocol.Materials and Methods
This retrospective study was conducted at the Depart-
ment of Pathology, King Fahd Hospital of the University of
Dammam after the mandatory approvals. An audit and re-
evaluation of RM specimens received from 1st January
2012 to 30th December 2014 was conducted.
The inclusion criteria were all RM specimens received
during the period under review (3 years) for whom hospital
record of patient, complete set of paraffin blocks, and
histopathology diagnosis were available. Any specimen that
did not fulfil the above criteria was excluded from the
study.
Age, sex, indication for surgery, family history of breast
cancer, and radiological evaluation before surgery were
checked in the medical record of each patient. The number of
blocks sampled and macroscopic findings were recorded
from the pathology reports. A proforma-cum-checklist was
prepared to note age, gender, family history, pre-op
mammographic findings, indication for surgery, any spe-
cific findings noted at the time of surgery, number of blocks,
initial reported diagnosis, diagnosis at re-evaluation, any
discrepancy between the two diagnoses, and specific detailed
microscopic findings. Three categories of cases were devel-
oped based on the number of paraffin blocks made at the
time of grossing. These categories were designated as
Category-I: <4 blocks, Category-II: 5e8 blocks, and
Category-III: 8e12 blocks.
The re-evaluation was independently made by two
members of the team (AA & MAS). A detailed microscopic
report and final diagnosis were made and recorded sepa-
rately. The results of both the pathologists were later
compared. In case the results did not match, a third member
(AMN) also re-evaluated the case, and the results were dis-
cussed until a consensus was reached.
The microscopic diagnosis for each case was classified
into one of four categories5:(1) Normal or benign breast disease.
(2) Lesions of uncertain malignant potential, including
atypical ductal hyperplasia (ADH), atypical lobular hy-
perplasia (ALH), intraductal papilloma, and lobular
carcinoma in situ (LCIS).
(3) Ductal carcinoma in situ (DCIS) or microinvasive
carcinoma.
Histopathology of reduction mammoplasty136(4) Invasive carcinoma.
The current protocol for breast reduction specimens
received at our laboratory for histopathological examination
involves the specimen being sliced and examined macro-
scopically. If no lesion is grossly identified, an average of two
to three random blocks of breast tissue are taken from each
breast. If a macroscopic lesion is present, sampling is
concentrated on its vicinity, with selection of an appropriate
number of blocks being considered necessary by the
pathologist. A macroscopic abnormality is defined as the
presence of a discrete mass, cysts, or calcification. Fibrosis is
not included in this definition. If an important microscopic
finding is identified, further tissue blocks are taken. In most
cases, the specimens are received as multiple fragments and
are not oriented.Table 1: Parameters recorded in all reduction mammoplastyStatistical analysis
The collected data were entered in the SPSS-19 statistical
software package. Data were expressed using descriptive
statistics in the form of number and percentages for quali-
tative variables. Mean  standard deviation (SD) was
calculated for quantitative variables.
Based on the findings of audit and histopathological re-
evaluation, a prerequisites protocol for RM specimens was
proposed.specimens.
Parameters recorded Data available
(% of cases)
Age of the patient n ¼ 26 (100%)
Gender n ¼ 26 (100%)
Indication of surgery n ¼ 26 (100%)
Any specific findings noted at
the time of surgery
N.A
Family history N.A
Radiological diagnosis N.A
Initial reported diagnosis n ¼ 26 (100%)
Diagnosis at re-evaluation n ¼ 26 (100%)
Any discrepancy between
the two reported diagnosis
None
Number of blocks prepared per case. (<) 4, 5e8 and
8e12
N.A ¼ Not available.
Figure 1: Percentages of histopathological lesions in reduction
mammoplasty specimens (n ¼ 26).Results
We received a total of 27 cases of reduction mammo-
plasty specimens in three years. One case was excluded as it
lacked complete patient records and was also autolyzed. Out
of the final 26 cases of RM evaluated, most of the cases were
female (24/26). The age of the patients ranged from 26 to 50
years with a mean age of 33.33 9.17 years. The numbers of
blocks for these cases were in the range of <4 in 17 cases
(73.91%), 5e8 blocks in 5 cases (19.23%) and 8e12 blocks
in 4 cases (15.38%). All cases (100%) had either normal or
benign breast disease. Normal breast tissue was observed in
eight cases (30.77%), and benign breast disease was
observed in 18 cases (69.23%). The benign breast diseases
identified were lipomatous hyperplasia in two cases (7.69%),
fibrocystic changes in 12 cases (46.15%), mammary duct
ectasia in one case (3.85%), and marked foreign body
granulomatous reaction in one case (3.85%). In the latter,
the patient had a history of scar tissue removal from a
previous mammoplasty. The two males (7.69%) had
gynaecomastia. The spectrum of fibrocystic changes con-
sisted mainly of non-proliferative changes in seven cases
(58.33%), while proliferative changes were observed in five
cases (46.67%). The proliferative changes comprised mild to
florid epithelial ductal epithelial hyperplasia of the usual
type, sclerosing adenosis, and focal columnar cell change.
There were no lesions of uncertain malignant potential,
ductal carcinoma in-situ, or microinvasive or invasive
carcinoma.
The parameters recorded are presented in Table 1. The
percentages of main histopathological lesions in RM
specimens are presented in Figure 1, and surgical
indication for RM is presented in Table 2.Discussion
Breast tissues from RM procedures are commonly
encountered specimens in surgical pathology; however, no
well-defined guidelines are available for pathological exam-
ination of these specimens. Only a small number of reports
are available in the literature discussing histological findings
in RMs. The complete absence of any pre-malignant or
malignant lesions in these specimens in our study, as well as
the trend of implementing specimen radiography for gross
specimens, are the major issues to discuss.
In 1960, Snyderman and Lizardo reported a study on the
detection of malignant neoplasms in routine breast plastic
operations, including RM procedures. Of 5008 RM cases, 19
breast carcinomas were discovered pre-operatively by phys-
ical examination, intra-operatively by frozen section, and
post-operatively by routine histopathological evaluation.10
In 1998, Jansen and colleagues11 reported an incidence of
occult invasive breast carcinoma in 0.16% of 2576
specimens. Bondeson and colleagues reported seven cases
(8%) of lobular carcinoma in situ (LCIS) in patients older
than 40 years.12 In our set of cases, out of the total of 26
cases, only three patients were above the age of 40 years.
The microscopic findings comprised fibrocystic changes in
Table 2: Age-wise indication for reduction mammoplasty
(n[ 26).
Indication for RM Age < 35
No. (%)
Age  35
No. (%)
Macromastia 9 (34.62%) 14 (53.85%)
Developmental asymmetry 0 2 (7.69%)
Post procedure 0 1 (3.85%)
Total 9 (34.62%) 17 (65.38%)
A. Ahmed et al. 137two cases and mild epithelial proliferation of the usual type
in one along with lipomatous hyperplasia. In the same
study mentioned above, Bondenson et al found no
pathological abnormalities in all patients younger than 30
years. Based on the large amount of material generated by
RM specimens and minimal incidences of pathologically
and clinically serious lesions, the authors challenged the
concept of extensive sampling of all tissues. The authors
concluded that in patients younger than 30 years, careful
gross examination with or without minimal microscopic
examination (1 or 2 blocks) is adequate. Extensive
microscopic examination was recommended for specimens
from women older than 40 years, even in the absence of
grossly evident lesions.12 However, the definition of
extensive sampling has not been delineated to date. In the
cases described in this study, no suspicious areas were
detected grossly or microscopically, i.e., all were found to
be benign, and the number of blocks in the majority of
cases (73.91%) was less than four per case. The question
remains whether this extent of sampling was sufficient to
detect occult pre-malignant lesion, and determining a pre-
cise definition of parameters for grossing such samples is
warranted.
In our set of cases, there was a complete absence of inci-
dental carcinoma, despite the high prevalence rate of breast
cancer in Saudi women, which accounts for 27.4% of all
diagnosed female cancers in the year 2010.13 This
discrepancy could be attributed to our small sample size
compared to the studies documented above. Alternatively,
the cause might be attributed to missing a carcinoma by
not taking extensive sampling and not incorporating
radiological sampling parameters, as protocols for
sampling such specimens are not well-delineated to date.
A cut-off age limit of 35 years was made for indication for
surgery and radiological findings because mammographic
evaluation is recommended after 35 years, and risk of car-
cinoma and associated surgeries also change with increasing
age.14,15
Standard use of preoperative mammography is contro-
versial in patients considering RM. In a study conducted
between 2001 and 2005, screening mammography was
performed before reduction mammoplasty. Sixteen percent
of the patients were observed to have abnormal pre-
operative mammographic results, which all were deter-
mined to be false positive.16 Mammography is rarely used
by surgeons, as depicted in a multi-institutional analysis
conducted in UK and Ireland; the authors found that 72%
of clinicians never performed a pre-operative mammogram,
28% of clinicians only do a mammogram once before the
operation, and only one surgeon did a mammogram before,
as well as 6 months after, the operation.17 Similarly, nomammography was performed preoperatively in the cases
in this study. Ishag et al. demonstrated that patients
undergoing RM need to be stratified in three risk groups:
(1) ‘high-risk persons’ are those with a family history of
breast cancer, BRCA1 or BRCA2 mutations, or a
personal history of previous radiation to the chest or
cancer syndromes; (2) ‘intermediate-risk persons’ are those
with family history of breast cancer; and (3) ‘low-risk
persons’ are those under 30 years of age with no family
history of breast cancer. These researchers recommended
that specimen processing with orientation of margins and
inking of margins needs to be conducted in high-risk pa-
tients.18 In addition, a stratified group for mammographic
evaluation also needs to be formulated. Mammography
screening is associated with a 19% overall reduction of
breast cancer mortality but may also cause harm. For a
40 or 50-year-old woman undergoing 10 years of annual
mammograms, the cumulative risk of a false-positive
result is approximately 61%. The benefits of mammo-
graphic screening can be increased by personalizing it, i.e.,
the decision would be based on each “patient’s risk profiles
and preferences”.19
Although one out of every eight women has a risk of
developing breast cancer, the reported incidence of breast
carcinoma detection in RMmaterials is rather low. Specimen
radiography, which is used for breast biopsies, has not been
used for the assessment of breast reduction materials. Ozs-
men et al20 studied the applicability of specimen radiography
and its potential benefits in the detection of breast
pathologies in RM materials, especially malignancies.
Forty patients scheduled for RM were included. In all
cases, an inferior pedicle reduction technique was
preferred, and the radiographs of the resected breast tissues
were taken immediately. The radiographs were evaluated
for any possible pathological appearance and all abnormal
findings were marked. For histopathological evaluation, in
addition to the random sampling by the pathologist, any
marked areas were also microscopically examined. In two
cases, fibrocystic changes were observed in radiographs,
and the same results were obtained by histological
examination. No false negative mammograms were
observed. Specimen radiography, which is applicable for
breast reduction materials, is an easy and cheap method
and does not cause any patient discomfort. The
radiographs of RM materials are useful to provide
guidance to the pathologist during tissue sampling for
microscopic examination, especially when large amounts of
breast tissue are excised.
In our study, the primary indication for surgery was
macromastia in 12 cases, developmental asymmetry in two
cases, and post-procedure in one case. It is debatable whether
these indications justify undergoing a major operative pro-
cedure with its inherent surgical complications. Macro-
mastia, or breast hypertrophy and asymmetry, is a highly
common finding and a frequent cause of reduction mam-
moplasty all over the world.21 One school of thought
considers undergoing surgery for symmetry to be irrelevant
as they advocate that asymmetry is “the normal”, there is
no perfect symmetry in the human body, and searching for
it is basically a sign of psychological and psychiatric
disorders. For evaluation of the extent of surgical
complications associated with RM, one study has
Table 3: Proposed prerequisites and histopathology evaluation protocol for reduction mammoplasty.
History
Age <35 >35
Gender Female Male
Family History Positive Negative
Ultrasonography
Mammography
Laboratory protocol
a. If age is <35, any gender, and all other are negative in the history above
Routine 2-4 blocks per case, random sampling
b. If age is > 35 and gender is female and family history of breast cancer and 
radiology suspicious.
Orientation of the specimen with inking of margins more than 12 blocks per 
specimen.
c. Specimen radiography to be included in all specimens in which pre-op 
mammography is not performed in category b. 
Histopathology of reduction mammoplasty138documented a prospective evaluation of wound
complications in two hundred eighty-six reduction pro-
cedures. Fifty-two patients underwent reduction mammo-
plasty for macromastia, and 101 did so for macromastia with
breast cancer. The wound complications were divided into
minor and major complications. Seroma, hematoma, surgi-
cal site infection, delayed wound healing, and minor wound
dehiscence were included in the minor complication group.
Severe complications were necrosis of nippleeareola com-
plex and major incisional wound dehiscence.22 RM may be
limited for overweight and obese women for fear of
complications.23 Correlation between obesity and deficient
wound healing has long been established.24 However, the
results of these studies suggest that RM is a safe cosmetic
procedure in all patients, and obesity does not increase the
complication risk.
Based on the audit, our results, and a discussion, we
prepared a prerequisites protocol that is outlined in Table 3.Conclusions
Reduction mammoplasty is a common surgical procedure
used for cosmetic reasons, symptomatic macromastia, or
correction of asymmetry. This procedure produces a variable
amount of tissue that is submitted for histopathological
evaluation, with only several random sections usually being
sampled. Most of the cases are determined to be benign, but
rarely, occult breast carcinomas have been documented; this
finding justifies a highly detailed and thorough histopatho-
logical evaluation for all RM specimens. There was no inci-
dental carcinoma detected in our study, which has an
inherent limitation of a notably small sample size. However,
in all cases of RM, the surgeons should undertake a preop-
erative screening, consisting of a recommended triple breast
evaluation; taking a detailed patient history, specifically any
personal or family history of breast cancer; a clinical exam-
ination; and imaging by either a mammogram or breast
ultrasound.Recommendations
There is a need to stratify RM cases as high-, moderate-,
and low-risk of breast cancer based on the family history of
breast carcinoma and clinical and radiological evaluation.
The high-risk cases should undergo a detailed gross exami-
nation with precise orientation, inking of margins, and
extensive sampling. In addition, specimen radiography
should be performed in younger patients for whom
mammography is not recommended.Conflicts of interest
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